Clinical study of Longchaijiangxue granules in the treatment of myeloproliferative neoplasms

Not Applicable

Recruiting

• Conditions: myeloproliferative neoplasms

• Registration Number: ITMCTR2200005730
• Lead Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Meets WHO diagnostic criteria for PV, ET.
(2) PLT < 1000 x 109/L and HCT < 60%.
(3) Age above 18 years (including 18 years) and below 80 years (including 80 years), with no restriction on gender.
(4) Voluntarily subjected to the trial and signed an informed consent form.
(5) Not participating in other clinical studies.

Exclusion Criteria

(1) Cases that met the inclusion criteria but were not treated after inclusion.
(2) Patients with no record of testing.
(3) Those using prohibited drugs.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gene detection;Routine Blood Test(WBC\RBC\PLT\HGB etc.);Coagulation items;